Tag: Awakn Life Sciences

August 26, 2021

Awakn Life Sciences CEO Anthony Tennyson: Developing and Delivering the Next Generation of Addiction Treatments

"We’ll treat people with proprietary therapy, proprietary compounds, and well trained staff in a specifically designed clinical environment,” Awakn Life...
June 18, 2021

Awakn Life Sciences Corp. Announces Completion of Reverse Takeover Transaction, Release from Escrow of Private Placement Proceeds, and Final Approval for Listing on Neo Exchange

Awakn Life Sciences Corp. (formerly 1169082 B.C. Ltd.) is pleased to announce that it has completed its reverse takeover transaction...
May 17, 2021

Awakn Life Sciences Inc. and 1169082 B.C. Ltd. Enter into Binding Agreement for Reverse Takeover Transaction

Pursuant to the terms of the Amalgamation Agreement, the Proposed Transaction will be completed by way of a three-cornered amalgamation...
January 15, 2021

Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder

PRA Health Sciences selected for the study which will position Awakn at the Forefront of Psychedelic Research for Addiction Treatment